Regeneron Pharmaceuticals
Health Care
51
out of 100. Number 205 of 512, counting from the worst.
Where Regeneron Pharmaceuticals does well
- Renewals 0 of 20. Nothing found.
- The main website Terms do NOT impose forced arbitration — disputes go to New York state/federal courts, which is better than peers that bury a mandatory-arbitration clause.
- Regeneron explicitly pledges not to 'sell' or 'share' sensitive personal data (including health data from patient support programs) beyond purposes permitted by law, and not to knowingly sell/share data of children under
- They honor Global Privacy Control opt-out signals and provide a Privacy Preference Center, a dedicated rights webform, and a toll-free privacy line (1-844-835-4137).
- The RGC Data Privacy Statement commits not to reidentify deidentified genetic/health data and frames research data handling as ethical stewardship.
- Privacy notice changes that materially affect your consents must get your consent again where legally required — a commitment many peers skip.
If you have any dispute with Regeneron over its website, you give up your right to join or start a class action — you can only sue alone.
The fine print
6 clauses and findings from the draft archive, dated 1 October 2026. The plain English comes first; the small print is the company's own words. None of these has been checked yet.
-
If you have any dispute with Regeneron over its website, you give up your right to join or start a class action — you can only sue alone.
To the maximum extent permitted by applicable law, you agree that no dispute regarding the Website ("Covered Claims") may be initiated or maintained on a class action, collective action, or representative action basis either in court or arbitration... you may not participate as a plaintiff or claimant in a class, collective or representative action to the extent that the action asserts Covered Claims against us.
-
On Regeneron's genetics research websites you cannot sue in court at all — every dispute goes to a private, confidential arbitrator in New York, and you cannot combine claims with other people.
Any dispute relating in any way to your use of the Website or the Content shall be submitted to confidential arbitration in New York... Arbitration under this Agreement shall be conducted under the rules then prevailing of the American Arbitration Association. The arbitrator's award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement shall be joined to an arbitration involving any other party subject to this Agreement, whether through class arbitration proceedings or otherwise. ... Waiver of Class, Collective, and Representative Actions:
RGC Research Terms (Million Exome Variant Browser / MCPS Variant Browser) — https://rgc-research.regeneron.com/ and https://rgc-mcps.regeneron.com/
-
Regeneron admits it sells or shares your name, contact details, IP address, device IDs, browsing history, and even inferred profile data to advertising networks for targeted ads — they just define it in legal scare-quotes.
The chart below describes the categories of Personal Data that we collect and the categories of third-parties to whom we may disclose, "sell," or "share" each category of Personal Data for the purposes set out in the section on How We Use Your Information. We may "sell" or "share" your Personal Data for cross-context behavioral advertising purposes (as those terms are defined under applicable law).
-
Patient support programs collect your diagnoses, treatments and insurance details from you, your doctor, and your insurer. Once Regeneron strips the identifiers, that health data can be used for anything — including drug development — and the privacy rules no longer apply to it.
If you participate in a Regeneron patient support program, we collect Personal Data directly from you, or from your healthcare provider (HCP), payor, or related third parties, such as your individual health conditions, diagnoses, and treatments, insurance information, and prescribing physician information... We may aggregate, deidentify, or anonymize your Personal Data for any purpose permitted under applicable law, such as analytics, research and publication, and the development and improvement of Regeneron's programs and related services, products, and medicines.
-
Regeneron can rewrite the rules whenever it wants with zero notice — just visiting the site again counts as you agreeing to the new version.
We reserve the right, in our sole discretion, to change these Terms and Conditions at any time by posting the changes on the Website. Any changes are effective immediately upon posting to the Website. Your continued use of the Website constitutes your agreement to all such terms and conditions.
-
Anything you send Regeneron — feedback, ideas, even a job application — they can use forever, sell, and turn into products without paying you a cent.
By transmitting or posting any Submission, you hereby grant us a nonexclusive, royalty-free, fully paid up, perpetual, transferable, irrevocable, and fully sublicensable right to use, reproduce, modify, adapt, publish, sell, assign, translate, create derivative works from, distribute and display any Submission in any form, media or technology, whether now known or hereafter developed, alone or as part of other works. You also acknowledge that we may use your Submission, and any ideas, concepts or know how contained therein, for any purpose including, without limitation, developing, manufacturing, distributing and marketing products.
How these were found
Documents read via browser_open on Oct 1, 2026: Regeneron Terms of Use, marked 'Updated May 2025' (https://www.regeneron.com/terms); Regeneron Privacy Notice, marked 'Last updated November 20, 2025' (https://www.regeneron.com/privacy-notice). The forced-arbitration language for the RGC research sites (rgc-mcps.regeneron.com and rgc-research.regeneron.com) was captured from search-engine-crawled text of those official Regeneron domains (verbatim as crawled); the live pages are JavaScript apps whose full text did not render through the text fetcher, so the complete clause context on those pages was not independently re-verified. Quotes in this file are close paraphrases of the official wording (editorial cleanup of formatting) unless stated verbatim. No mirror archives (OpenTermsArchive, PrivacyTracker, Difficode) were needed. Patient-support-program enrollment forms and patient portal terms (which may carry additional arbitration or data terms) were not reviewed.
These notes come from the original draft and are not independent verification.